Feutune Light Acquisition Corporation Right
FLFVR
FLFVR was delisted on the 21st of June, 2024.
17 hedge funds and large institutions have $802K invested in Feutune Light Acquisition Corporation Right in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 6 reducing their positions, and 1 closing their positions.
78% more capital invested
Capital invested by funds: $450K → $802K (+$352K)
6% less funds holding
Funds holding: 18 → 17 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASM
ATW SPAC Management
New York
|
-$44K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$14.3K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$359 |
| 4 |
VF
Virtu Financial
New York
|
-$172 |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$72 |
FLFVR Hedge Fund Activity: Q4 2022 in Review
17 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Feutune Light Acquisition Corporation Right (FLFVR) for Q4 2022, worth a combined $802K — up 78% from $450K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FLFVR and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 0 added.
The largest seller was ATW SPAC Management, exiting entirely with an estimated $44K sold.
- 17 institutional investors held Feutune Light Acquisition Corporation Right (FLFVR) as of Q4 2022, down from 18 in Q3 2022.
- Funds reported $802K of Feutune Light Acquisition Corporation Right stock for Q4 2022, up 78% quarter-over-quarter.
- 0 funds opened new Feutune Light Acquisition Corporation Right positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest Feutune Light Acquisition Corporation Right seller in Q4 2022 was ATW SPAC Management, an estimated $44K sold.
Based on aggregated 13F filings for Q4 2022.